Atlas Trials

Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC

Clinical trial NCT06127303 · RECRUITING

Trial details

NCT number
NCT06127303
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2024-04-02
Primary completion
2026-04-02
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.